North American Vaccine Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine

NVX 1.280

-9.2%

9:42 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Bogdanoff who wrote (382)	7/11/1998 8:18:00 AM
From: Don W Stone	Read Replies (1) of 507

David: Good post. Have you seen the Montgomery Report on NVX? It is conservative and it does help one think more about the fundamentals that NVX has going for them and not be so negatively channeled to the FDA delays. I posted on Yahoo so go read it. NVX is way undervalued right now. Based on this report and other sources, with approval NVX should be trading in the hi $40's at least. The Montgomery analyst has NVX estimated eps for 1999 at just over $2.00 and for 2000 at over $3 . If the Company doesn't get bought out the stock will be trading alot higher than $60 within the year. If they do get bought out the price I am sure will be based on earnings projections to include Abbotts piece of the action plus some value for GBS. That number is well above $40 per share and just perhaps more realistically in the $80's. Who knows, Just maybe the big day will come next week. Things right now seem awful quiet. :-}

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next